Be A Prostate Cancer Research Reviewer! - Active Surveillan...

Active Surveillance - Prostate Cancer

665 members373 posts

Be A Prostate Cancer Research Reviewer!

Darryl profile image
DarrylPartner
0 Replies

The Department of Defense (DOD) Prostate Cancer Research Program (PCRP) is inviting Malecare members to review research for the FY20 DOD PCRP, which is part of the Congressionally Directed Medical Research Programs (CDMRP).

The PCRP has received Congressional Appropriations of over $1.8 billion and has funded approximately 3,368 awards. Thanks to advocacy by Malecare and others, FY20 Congress has again funded the PCRP with $110 Million. Next year, we will try to lead an effort to get a much higher level of funding.

We want to nominate you to review the impact of proposed research applications.

Reviewers who are prostate cancer patients serve on scientific peer review panels, together with scientist reviewers, to review research applications submitted to CDMRP for funding.

Individuals wishing to serve as a Consumer Reviewer in FY20 are required to contact me for:

1. The electronic nomination form, to be completed and sent by the nominee

2. Your current resume to be sent by the nominee

3. A letter of nomination to be sent by Malecare.

Nomination packets are due by Wednesday, March 18, 2020, so please make your request to me no later than March 7, 2020...indeed, email me now. You can email me at darrylm@malecare.org , with PCRP in the subject line.

I encourage you to explore the CDMRP website to learn more about the Prostate Cancer Research Program. The FY19 recommended for funding list has been posted as well as research highlights cdmrp.army.mil/pcrp/default...

Please contact me if you have questions about submitting a nomination letter or if you have other related questions.

Thank you for considering this opportunity to become a consumer reviewer for the PCRP! And, please share your experience below if you have already served as a reviewer. Thanks.

Written by
Darryl profile image
Darryl
Partner
To view profiles and participate in discussions please or .

Not what you're looking for?

You may also like...

ART Long-Term Mortality Low Regardless of Treatment in Local Prostate Cancer

Amazing! The headline states that there is ‘low’ mortality regardless of treatment for local...
RMontana profile image

Contrast MRI vs biopsy

Just wanted to share my experience with contrast pelvic/prostate 3T MRI and prostate 14 core biopsy...
Chumpsteak profile image

ART NIH Predicting the Outcome of Salvage Radiation Therapy for Recurrent Prostate Cancer After Radical Prostatectomy

Summary: Patients in this audience have had both radical prostatectomies (RP) and salvage radiation...
RMontana profile image

Most Recent MRI

Hello everyone, I am 72 and have been on active surveillance for prostate cancer since I was...
ironmanburg profile image

ART Radiation dose and ADT in localized PCa: a meta-regression of 5-year outcomes in phase III random control trials; 21,429 patients

I have had 21 months of ADT and also have decided to stop short of my suggested 24 months total...
RMontana profile image

Moderation team

Bethishere profile image
BethishereAdministrator
Number6 profile image
Number6Administrator
Darryl profile image
DarrylPartner

Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.

Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.